First Tracks Biotherapeutics Inc (TRAX)

NASDAQ · Biotechnology

41.57
-0.27 (-0.65%)
Updated Sep 1, 7:15 PM ET
AI Rating
Hold
Overall Score
53
Trend
75
Momentum
38
Risk
40

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Apr 6, 2026 103 sessions Aug 31, 2026

AI Analysis

First Tracks Biotherapeutics Inc is trading at $41.57, down 0.65% on the session. The 50 day average sits at $36.17 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 49.9, which reads as neutral, and MACD is bearish crossover. Volume is average.

The nearest support is around $40.72 with resistance near $42.90, so that band frames the current range. Average daily movement is roughly $3.11, or about 7.5% of the share price, which is what any stop placement has to allow for. The overall health score of 53 out of 100 combines a trend score of 75, momentum of 38 and a risk score of 40.

Technical indicators

RSI (14)
49.9
neutral
MACD
1.441
bearish crossover
SMA 20
44.57
SMA 50
36.17
SMA 200
--
unknown
ATR (14)
3.11
avg daily range
Support
40.72
Resistance
42.90
Volume vs 20d
1.04x
average
Volatility
55.3%
annualised
1 month
-5.00%
3 months
+131.29%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.